Medtech that matters

As healthcare challenges continue to grow, so does the need for innovative ways to meet them. 

Observe Medical develops medtech solutions that help ensure healthcare professionals and patients benefit from the highest standards of care safely and cost-effectively – and Sippi, the world’s first digital urine meter system, being our latest innovation. 

Sippi is brought to market via distributors and direct sales channels in the Nordics, which also offer a wide selection of other medtech products within anesthesia, intensive care, infusion, surgery, wound care and temperature management.   

Innovation for healthcare needs

The prevalence and cost of hospital acquired infection are growing challenges for healthcare facilities. Sippi alerts for and hinders biofilm formation, thus reducing a risk factor for urinary infection.

Nordic solutions to global challenges

Observe Medical is a Nordic medtech company that develops, markets and sells innovative medtech products for the global market. The Company is headquartered in Oslo, Norway, with additional offices in Narvik, Norway and Gothenburg, Sweden, and subsidiaries in Finland and the US.

Our newsfeed

Observe Medical ASA – Minutes from Annual General Meeting

Observe Medical ASA has today, June 3, 2022, held the Annual General Meeting. All resolutions were made in accordance with the board's and the nomination committee's proposals. The minutes from the general meeting is attached hereto and will also be available at For further information, please contact:   Rune Nystad, CEO Observe Medical Mobile:…

Read more

Observe Medical ASA: Business update and first quarter 2022 presentation

Oslo, 3 June 2022 – Observe Medical ASA (OSE: OBSRV) (“the Company” or “Observe Medical”) today releases its first quarter results for 2022. Observe Medical has made progress across its medtech platform during the quarter, preparing and strengthening it for growth. The Company has also streamlined the organization and other operational synergies following the acquisition…

Read more